syd presso today, page-52

Not holding but still watching, the last days sp decline could be related to an article about PRR, written by an E-trade analyst "undertheradar", which shows in a brutal way
the reality of getting new technologies developed and marketed.

ANP is going a different way but the risks are the same. The lower the sp the more time to get on board if the picture becomes clearer. Even with great news a re-entry at about 2c seems very achievable. That's what the market could be thinking, there is no need to rush to avoid to left behind.

The big mistake was the panic to do the CR, a clear signal that the expected support by the big pharma(s) hasn't been achieved, yet.

If the phase 2 trials will be succesful then of course there will be a new ANP story, but until then, not much will happen. A t/o is very unlikely, as the scientists of ANP are the real value, not the comp. So, any t/o would be in reality a big pharma luring ANP's staff to their comp. ANP got already fantastic intellectuell properties, but worthless without the scientists to continue.

GL to all, sadly to see that Stocky got it right, sp at 1.6c.